Schrödinger, Inc. (SDGR)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Ramy Farid Ph.D. | CEO, President & Director | 1.24M | -- | 1965 |
| Dr. Richard A. Friesner Ph.D. | Co-Founder, Scientific Advisory Chairman and Director | 473.4k | -- | 1953 |
| Dr. Geoffrey Craig Porges MBBS | Executive VP & CFO | 1.04M | -- | -- |
| Mr. Kenneth Patrick Lorton | Executive VP, CTO & COO of Software | 736.84k | 113.71k | 1984 |
| Dr. Robert Lorne Abel Ph.D. | Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D | 736.84k | -- | 1982 |
| Dr. Karen Akinsanya Ph.D. | President of Research & Development Therapeutics | 931.41k | -- | 1968 |
| Prof. William Goddard III | Co-Founder & Scientific Advisor | -- | -- | -- |
| Mr. Shane Brauner | Executive VP & Chief Information Officer | -- | -- | 1978 |
| Ms. Jaren Irene Madden | Senior Vice President of Investor Relations & Corporate Affairs | -- | -- | -- |
| Ms. Yvonne Tran Esq. | Corporate Secretary, Chief Legal & People Officer | 670.1k | -- | 1971 |
Schrödinger, Inc.
- Sector:
- Healthcare
- Industry: Health Information Services
- Full Time Employees:
- 891
Description
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Corporate Governance
Upcoming Events
July 29, 2025 at 10:59 AM UTC - August 4, 2025 at 12:00 PM UTC
Schrödinger, Inc. Earnings Date